Jingyao Wei

409 total citations · 1 hit paper
15 papers, 279 citations indexed

About

Jingyao Wei is a scholar working on Molecular Biology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingyao Wei has authored 15 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingyao Wei's work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers) and Flavonoids in Medical Research (3 papers). Jingyao Wei is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers) and Flavonoids in Medical Research (3 papers). Jingyao Wei collaborates with scholars based in China, United Kingdom and Germany. Jingyao Wei's co-authors include Xin Tian, Yueqin Wang, Yun‐Gui Yang, Lulu He, Ouwen Li, Quancheng Kan, Ke An, Yue Du, Xiaojian Zhang and Lan Huang and has published in prestigious journals such as Molecules, Molecular Cancer and European Journal of Pharmacology.

In The Last Decade

Jingyao Wei

13 papers receiving 278 citations

Hit Papers

Aberrant m5C hypermethylation mediates intrinsic resistan... 2023 2026 2024 2025 2023 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer
    2023 121 citations Yueqin Wang, Jingyao Wei et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingyao Wei China 9 186 90 42 39 33 15 279
Leyan Li China 10 153 0.8× 101 1.1× 42 1.0× 34 0.9× 80 2.4× 15 289
Xiaona Lu China 10 132 0.7× 61 0.7× 26 0.6× 61 1.6× 56 1.7× 22 252
Qian Zuo China 10 206 1.1× 78 0.9× 34 0.8× 72 1.8× 56 1.7× 14 352
Weijie Qiang China 8 169 0.9× 65 0.7× 35 0.8× 69 1.8× 95 2.9× 14 327
Fanqin Zhang China 9 125 0.7× 62 0.7× 21 0.5× 45 1.2× 63 1.9× 20 229
Win Lwin Thuya Singapore 8 192 1.0× 44 0.5× 32 0.8× 64 1.6× 32 1.0× 11 304
Juanjuan Han China 6 253 1.4× 146 1.6× 15 0.4× 34 0.9× 22 0.7× 8 393
Hai Zhu China 9 191 1.0× 114 1.3× 73 1.7× 73 1.9× 17 0.5× 18 436
Hongchao Yuan Hong Kong 9 118 0.6× 66 0.7× 29 0.7× 41 1.1× 31 0.9× 12 249
Yuxin He China 11 189 1.0× 78 0.9× 71 1.7× 23 0.6× 27 0.8× 22 337

Countries citing papers authored by Jingyao Wei

Since Specialization
Citations

This map shows the geographic impact of Jingyao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyao Wei more than expected).

Fields of papers citing papers by Jingyao Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyao Wei. The network helps show where Jingyao Wei may publish in the future.

Co-authorship network of co-authors of Jingyao Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyao Wei. A scholar is included among the top collaborators of Jingyao Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyao Wei. Jingyao Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Han, Yueqin Wang, Lan Huang, et al.. (2025). Targeting YBX1‐m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma. Clinical and Translational Medicine. 15(3). e70270–e70270. 9 indexed citations
2.
Chen, Haoyang, et al.. (2025). Integration of transcriptomics and metabolomics to reveal crizotinib-induced liver injury in mice. European Journal of Pharmacology. 1006. 178096–178096.
3.
Wang, Yueqin, et al.. (2025). METTL1/WDR4-mediated m7G Hypermethylation of SCLT1 mRNA Promotes Gefitinib Resistance in NSCLC. Genomics Proteomics & Bioinformatics.
4.
Zhang, Xuran, Ke An, Xin Ge, et al.. (2024). NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation. Breast Cancer Research. 26(1). 94–94. 28 indexed citations
5.
6.
Wang, Yueqin, Jingyao Wei, Ouwen Li, et al.. (2023). Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Molecular Cancer. 22(1). 81–81. 121 indexed citations breakdown →
7.
Wei, Jingyao, Ruijuan Liu, Jiali Zhang, et al.. (2021). Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption. Frontiers in Pharmacology. 12. 761763–761763. 8 indexed citations
8.
Wei, Jingyao, et al.. (2020). An UPLC-MS/MS Method for Determination of Osimertinib in Rat Plasma: Application to Investigating the Effect of Ginsenoside Rg3 on the Pharmacokinetics of Osimertinib. International Journal of Analytical Chemistry. 2020. 1–9. 9 indexed citations
9.
Liu, Ruijuan, Xia Li, Jingyao Wei, et al.. (2019). A Single Dose of Baicalin Has No Clinically Significant Effect on the Pharmacokinetics of Cyclosporine A in Healthy Chinese Volunteers. Frontiers in Pharmacology. 10. 518–518. 9 indexed citations
10.
11.
Tian, Xin, et al.. (2019). Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats. Journal of Pharmacy and Pharmacology. 71(5). 788–796. 8 indexed citations
12.
Liu, Ruijuan, Fang Zhou, He He, et al.. (2018). Metabolism and Bioactivation of Corynoline With Characterization of the Glutathione/Cysteine Conjugate and Evaluation of Its Hepatotoxicity in Mice. Frontiers in Pharmacology. 9. 1264–1264. 8 indexed citations
13.
14.
Gao, Na, Xin Tian, Yan Fang, et al.. (2016). Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes. European Journal of Pharmaceutical Sciences. 92. 86–97. 40 indexed citations
15.
Tian, Xin, Yuhai Zhang, Jingyao Wei, et al.. (2016). LC-MS/MS Analysis and Pharmacokinetics of Sodium (±)-5-Bromo-2-(α-hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-Ischemic Stroke Agent in Rats. Molecules. 21(4). 501–501. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leyan Li Breakdown of academic impact, for papers by Xiaona Lu Breakdown of academic impact, for papers by Qian Zuo Breakdown of academic impact, for papers by Weijie Qiang Breakdown of academic impact, for papers by Fanqin Zhang Breakdown of academic impact, for papers by Win Lwin Thuya Breakdown of academic impact, for papers by Juanjuan Han Breakdown of academic impact, for papers by Hai Zhu Breakdown of academic impact, for papers by Hongchao Yuan Breakdown of academic impact, for papers by Yuxin He
Rankless by CCL
2026